Abstract
New or improved vaccines require testing before they are licensed for use in the general population. Although toxicity and immunological data can be obtained from Phase I human trials, in the vast majority of cases it is not possible to demonstrate efficacy by challenging vaccine recipients with the specific infectious agent. Therefore, prior to large-scale production of vaccines and their assessment in Phase II and III clinical trials, there is a requirement for in vivo studies that can predict the level of protection that may be expected from a vaccine. Although many animal models are available for infectious disease studies, they all rely on the animal’s own immune system for the generation of the protective responses, and these may not reflect the immunological responses generated in humans. The route of challenge that must be used in order to achieve infection is often not the same as the one that occurs in human disease, and this further confounds the relevance of the animal model. In addition, some infections are specific to humans, and it is sometimes impossible to find a suitable animal species that human pathogens will infect. This may be because of the lack of appropriate receptors, the presence of a functional immune system able to eliminate the pathogen, or the fact that models cannot always be relied on to re-create the normal pathophysiology. In some cases, this resistance to infection can be overcome by the development of a transgenic animal in which the appropriate receptors are expressed. The development of transgenic models has been directed toward genetic disorders or dissection of the immune system by gene-knockout technology.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
McCune, J. M., Namikawa, R., Kaneshima, H., Shultz, L. D., Lumberman, M., and Welshman, I. L. (1988) The SCID-Hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241, 1632–1639.
Mosier, D. E. (1990) Immunodeficient mice xenografted with human lymphoid cells: new models for in vivo studies of human immunobiology and infectious diseases. J. Clin. Immunol. 10, 185–191.
Mosier, D. E., Gulizia, R. J., MacIsaac, P., Mathieson, B. J., Smith, G., Hu, S. L., et al. (1992) Evaluation of gpl60 vaccinees in the hu-PBL-SCID mouse model. AIDS Res. Hum. Retrovir. 8, 1387.
Mosier, D. E., Gulizia, R. J., Baird, S. M., Wilson, D. B., Spector, D. H., and Spector, S. A. (1991) Human immunodeficiency virus infection of human-PBL-SCID mice. Science 251, 791–794.
Torbett, B. E., Picchio, G., and Mosier, D. E. (1991) Hu-PBL-SCID mice-a model for human immune function, AIDS, and lymphomagenesis. Immunol. Rev. 124, 139–164.
Mosier, D. E., (1996) Viral pathogenesis in hu-PBL-SCID mice. Semin. Immunol. 8, 255–262.
Levine, B., Hardwick, J. M., Trapp, B. D., Crawford, T. O., Bollinger, R. C, and Griffin, D. E. (1991) Antibody-mediated clearance of alphavirus infection from neurons. Science 254, 856–860.
Baiocchi, R. A. and Caligiuri, M. A. (1994) Low dose interleukin 2 prevents the development of Epstein-Barr virus (EBV) associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 91, 5577–5581.
Berney, T., Damarism Molano, R., Pileggi, A., Cattan, P., Li, H., Ricordi, C., and Inverardi, L. (2001) Patterns of engraftment in different strains of mice reconstituted with human peripheral blood lymphocytes. Transplantation 72, 133–140.
Carballido, J. M., Namikawa, R., Carballido-Perrig, N., Antonenko, S., Roncarolo, M. G., and de Vries, J. E. (2000) generation of primary antigen-specific human T-and B-cell responses in immunocompetent SCID-hu mice. Nat. Med. 6, 103–106.
Zhang, Z., Jin, L., Champion, G., Seydel, K. B., and Stanley S. L. (2001) Shigella infection in a SCID mouse-human intestinal xenograft model: a role for neutrophils in containing bacterial dissemination in human intestine. Infect. Immun. 69, 3240–3247.
Hall, G. A, Hodgeson, A. E, Leach, S. A, Dennis, M. J., Cawthraw, S., and Newell, D. (1999) Experience with intestinal xenografts to model Campylobacter infection. European Soc. Vet. Pathol. 17th meeting, Nantes, p. 167.
Scaramuzzino, D. A., McNiff, J. M., and Bessen, D. E. (2000) Humanized in-vivo model for streptococcal impetigo. Inf. Immun. 68, 2880–2887.
Bidanset, D. J., Ryback, R. J., Hartline, C. B., and Kern, E. R. (2001) Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissue. J. Infect. Dis. 184, 192–195.
Ilan, E., Arazi, J., Nussbaum, O., Zauberman, A., Erin, R., Lubin, I., et al. (2002) The Hepatitis C virus (HCV)-trimera mouse: A model for evaluation of agents against HCV. I. Infect. Dis. 185, 153–161.
Kish, T. M., Budgeon, L. R., Welsh, P. A., and Howett, M. K. (2001) Immunological characterization of human vaginal xenografts in immunocompromised mice: development of a small animal model for the study of HIV-1 infection. Am. J. Pathol. 159, 2331–2345.
Segall, H., Lubin, I., Marcus, H., Canaan, A., and Reisner, Y. (1996) Generation of primary antigen-specific human CTL in human/mouse radiation chimera. Blood 88, 721–730.
Marusic, C., Rizza, Lattanzi, L., Mancini, C., Spada, M., Bellardelli, F., et al. (2001) Chimeric plant virus particles as immunogens for inducing murine and human immune responses against HIV-1. J. Virol. 75, 8434–8439.
Delhem, N., Hadida, F., Gorochov, G., Carpentier, F., de Cavel, J. P., Andreani, J. F., et al. (1998) Primary Th1 cell immunization against HIVgp160 in SCID-hu mice co-engrafted with peripheral blood lymphocytes and skin. J. Immunol. 161, 2060–2069.
Duchosal, M. A., Fuzzati-Armentero, M. T., Baccala, R., Layer, A., Gonzalez-Quintial, R., Leturq, M. R., et al. (2000) Human adult tonsil xenotransplantation into SCID mice for studying human immune responses and B-cell lymphomagenesis. Exp. Hematol. 28, 177–192.
Albert, S. E., McKerlie, C., Pester, A., Edgell, B. J., Carlyle, J., Petric, M., et al. (1997) Time-dependent induction of protective anti-influenza immune responses. J. Immunol. 159, 1393–1403.
Holscher, C., Hasch, G., Joswig, N., Stauffer, U., Muller, U., and Mossman, H. (1999) Long-term substitution and specific immune responses after transfer of bovine peripheral blood lymphocytes into severe combined immunodeficient mice. Vet. Immunol. Immunopathol. 70, 67–83.
Murphey, W. J., Funarkoski, S., Fanslow, W. C., Rager, H. C., Taub, D. D., and Longo, D. L. (1999) CD40 stimulation promotes human secondary immunoglobulin reponses in HuPBL-SCID chimeras. Clin. Immunol. 90, 22–27.
Sandhu, J., Shpitz, B., Gallinger, S., and Hozumi, N. (1994) Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. J. Immunol. 152, 3806–3813.
Tournoy, K. G., Depraetere, S., Pauwels, R. A., and Leroux-Roels, G. G. (2000) Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice. Clin. Exp. Immunol. 119, 231–239.
Mead, J. R., Arrowood, M. J., Healey, M. C., and Sidwell, R. W. (1991) Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes. J. Protozool. 38, 59S–61S.
Sarin, P. S., Talmadge, J. E., Heseltine, P., Murcar, N., Gendelman, H. E., Coleman, R., et al. (1999) Booster immunization of HIV-1 negative volunteers with HGP-30 vaccine induces protection against HIV-1 virus challenge in SCID mice. Vaccine 17, 64–71.
Nguyen, H., Hay, J., Mazzuli, T., Gallinger, S., Sandhu, J., Teng, Y-T. A., and Hozumi, N. (2000) Efficient generation of respiratory syncitial virus (RSV)-neutralizing human MoAbs via human peripheral blood lymphocyte (huPBL)-SCID mice and scFv phage display libraries. Clin. Exp. Immunol. 122, 85–93.
Baiocchi, R. A., Ward, J. S., Carrodeguas, L., Eisbeis, C. F., Peng, R., Roychowdhury, S., et al. (2001) GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder. J. Clin. Investig. 108, 887–894.
Gupta, M., Mahanty, S., Bray, M., Ahmed, R., and Rollin, P. E. (2001) Passive transfer of antibodies protects immunocompetent and immunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. J. Virol. 75, 4649–4654.
Gaudin, M. C., Allaway, G. P., Olson, W. C., Weir, R., Maddon, P. J., and Koup, R. A. (1998) CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolates. J. Virol. 72, 3475–3478.
Fowler, K., McBride, B. W., Turnbull, P. C., and Baillie, L. W. (1999) Immune correlates of protection against anthrax. J. Appl. Microbiol. 87, 305.
Bosma, M. J. and Carroll, A. M. (1991) The SCID mouse mutant: definition, characterization, and potential uses. Annu. Rev. Immunol. 9, 323–350.
Jhappan, C., Morse, H. C., Fleischmann, R. D., Gottesman, M. M, and Merlino, G. (1997) DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus. Nat. Genet. 17, 483–486
Hinkley, K. S., Chiasson, R. J., Prior, T. K., and Riggs, J. E. (2002) Age-dependent increase of peritoneal B-1b B-cells in SCID mice. Immunology 105, 196–203.
Garcia, S., Dadaglio, G., and Gougeon, M. L. (1997) Limits of the Human-PBL-SCID mice model: severe restrictions of the Vβ T-cell repertoire of engrafted human T-cells. Blood 89, 329–336.
Nonoyama, S., Smith, F. O., Bernstein, I. D., and Ochs, H. (1993) Strain-dependent leakiness of mice with severe combined immune deficiency. J. Immunol. 150, 3817–3824.
Anderson, M. R. and Tary-Lehmann, M. (2001) Staphylococcal enterotoxin-B-induces lethal shock in mice is T-cell dependent but disease susceptibility is defined by the non T-cell compartment. Clin. Immunol. 98, 85–94.
MacDougall, J. R., Croy, B. A., Chapeau, C., and Clark, D. A. (1990) Demonstration of a splenic cytotoxic effector cell in mice of genotype SCID/SCID.BG/BG. Cell. Immunol. 130, 106–117.
Mosier, D. E., Stell, K. L., Gulizia, R. J., Torbett, B. E., and Gilmore, G. L. (1993) Homozygous scid/scid-beige/beige mice have low levels of spontaneous or neonatal T-cell-induced B-cell generation. J. Exp. Med. 177, 191–194.
Froidevaux, S. and Loor, F. (1991) A quick procedure for identifying doubly homozygous immunodeficient scid beige mice. J. Immunol. Methods 137, 275–279.
Shultz, L. D., Schweitzer, P. A., Christianson, S. W., Gott, B., Schweitzer, I. B., Tennent, B., Mckenna, S., Mobraaten, L., Rajan, T. V., and Geiner, D. L. (1995) Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154, 180–191.
Greiner, D. L. and Shultz, L. D. (1998) The use of NOD/LtSz-scid/scid mice in biomedical research, in NOD Mice and Related Strains: Research Applications in Diabetes, AIDS, Cancer and Other Diseases. (Leiter, E. and Athinson, M., eds.) Landes Bioscience, Austin, TX pp. 173–203.
Dick, J. E., Guenechea, G., Gan, O. I., and Dorrell, C. (2001) In vivo dynamics of human stem cell repopulation in NOD/SCID mice. Ann. NY Acad. Sci. 938, 184–190.
Lapidot, T. (2001) Mechanism of human stem-cell migration and repopulation of NOD/SCID and B2mnull mice: The role of SDF-1/CXCR4 interactions. Ann. NY Acad. Sci. 938, 83–95.
Kollet, O., Peled, A., Byk, T., Ben-Hur, H., Greiner, D., Shultz, L., and Lapidot, T. (2000) β2 microglobin-deficient (B2mnull) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 95, 3102–3105.
Kerre, T. C., De Smet, G., De Smet, M., Zippelius, A., Pittet, M. J., Langerak, A. W., de Bosscher, J., Offner, F., Vanderkerchove, B., and Plum, J. (2002) Adapted NOD/SCID model supports development of phenotypically and functionally mature T-cells from human umbilical cord blood CD34(+) cells. Blood 99, 1620–1626.
Hogan, C. J., Shpall, E. J., McNulty, O., McNiece, I., Dick, J. E., Shultz, L. D., and Keller, G. (1997) Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 90, 85–96.
Hogan, C. J., Shpall, E. J., McNiece, I., and Keller, G. (1997) Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34(+) peripheral blood progenitor cells. Biol. Blood Marrow Transplant 3, 236–246.
Shinkai, Y., Rathbun, G., Lam, K.-P., Oltz, E. M., Stewart, V., Mendelsohn, M., et al. (1992) RAG-2-Deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855–867.
Shultz, L. D., Lang, P. A., Christianson, S. W., Gott, B., Lyons, B., Umeda, S., et al. (2000) NOD/LtSz-Rag/null mice: an immunodeficient and radio-resistant model for engraftment of human hematolymphoid cells, HIV infection and adoptive transfer of NOD mouse diabetogenic T-cells. J. Immunol. 164, 2496–2507.
Aaberge, I. S., Michaelsen, T. E., Rolstad, A. K., Groeng, E. C., Solberg, P., and Lovik, M. (1992) SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection. Infect. Immunol. 60, 4146–4153.
He, X., Weyand, C. M., Goronzy, J. J., Zhong, W., and Stuart, J. M. (2002) Bi-directional modulation of T-cell-dependent antibody production by prostaglandin E(2) Int. Immunol. 14, 69–77.
Wedderburn, L. R., Jeffery, R., White, H., Patel, A., Vaarsini, H., Lind, D., et al. (2001) Autologous stem cell transplantation for paediatric-onset polyarthritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T-and B-cell repertoires and evidence for reversion from CD45RO(+) to RA(+) phenotype. Rheumatology 40, 1299–1307.
Giorgi, J. V., Hausner, M. A., and Hultin, L. E. (1999) Detailed immune phenotype of CD8+ memory cyotoxic T-lymphocytes (CTL) against HIV-1 with respect to expression of CD45RA/RO, CD62L and CD28 antigens. Immunol. Lett. 66, 105–110.
Roncarolo, M. G., Carballido, J. M., Rouleau, M., Namikawa, R., and de Vries, J. E. (1996) Human T-and B-cell functions in SCID-hu mice. Semin. Immunol. 8, 207–213.
Mosier, D. E., Gulizia, R. J., MacIsaac, P. D., Corey, L., and Greenberg, P. D. (1993) Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gpl60 and recombinant gpl60. Proc. Natl. Acad. Sci. USA 90, 2443–2447.
Van Kuyk, R., Torbett, B. E., Gulizia, R. J., Leath, S., Mosier, D. E., and Koenig, S. (1994) Cloned human CD8+ T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-l infection by an HLA-unrestricted mechanism. J. Immunol. 153, 4826–4833.
Williams, A., McBride, B. W., Hall, G., Fitzgeorge, R. B., and Farrar, G. H. (1995) Experimental legionnaires disease in SCID-Beige mice reconstituted with human leukocytes. J. Med. Microbiol. 42, 433–441.
Ono, M., Wada, Y., Wu, Y., Nemori, R., Jinbo, Y., Wang, H., et al. (1997) FP-21399 blocks HIV envelope protein-mediated membrane fussion and concentrates in lymph nodes. Nat. Biotechnol. 15, 343–348.
Di Fabio, S., Giannini, G., Lapenta, C., Spada, M., Binelli, A., Germinario, E., et al. (2001) Vaginal transmission of HIV in hu-SCID mice: a new model for the evaluation of vaginal microbicides. AIDS 15, 2231–2238.
Bahr, G. M., Darcissac, E. C., Casteran, N., Amiel, C., Cocude, C., Truong, M. J., et al. (2001) Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PGL-SCID mice. J. Virol. 75, 6941–6952.
Miura, Y., Misawa, N., Maeda, N., Inagaki, Y., Tanaka, Y., Ito, M., et al. (2001) Critical contribution of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T-cells in HIV-1 infected hu-PGL-NOD-SCID mice. J. Exp. Med. 193, 651–660.
Brooks, D. G. and Zack, J. A. (2002) Effect of latent human immunodeficiency virus infection on cell surface phenotype. J. Virol. 76, 1673–1681.
Mercer, D. F., Schiller, D. E., Elliott, J. F., Douglas, D. N., Hao, C., Rinfret, A., et al. (2001) Hepatitis C virus replication in mice with chimeric human livers. Nat. Med. 7, 890–891.
Santos, R. A., Hatfield, C. C., Cole, N. L., Padilla, J. A., Moffat, J. F., Arvin, A. M., et al. (2000) Varicella-zoster virus escape mutant VZV-MSP exhibits an accelerated cell-to cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology 275, 306–317.
Pletnev, A. G. (2001) Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3′ deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice. Virology 282, 288–300.
VanCott, J. L., McNeal, M. M., Flint, J., Bailey, S. A., Choi, A. H., and Ward R. L. (2001) Eur. J. Immunol. 31, 3380–3387.
Neyts, J. and De Clerq, E. (2001) Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl) purine for treatment of Vaccinia virus (Orthopoxvirus) infections in mice. Antimicrob. Agents. Chemother. 45, 84–87.
Yoshida, M., Watanabe, T., Usui, T., Matsunaga, Y., Shirai, Y., Yamori, M., et al. (2001) CD4 T-cells monospecific to ovalbumin produced by Escherichia coli can induce colitis upon transfer to Balb/c and SCID mice. Int. Immunol. 13, 1561–1570.
Wirtz, S., Becker, C., Blumberg, R., Galle, P. R., and Neurath, F. (2002) Treatment of T-cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing LI-18 antisense m RNA. J. Immunol. 168, 411–420.
Leriche-Guerin, K., Anderson, L. V., Wrogemann, K., Roy, B., Goulet, M., Tremblay, J. P. (2002) Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice. Neuromuscul. Disord. 12, 167–173.
Hodgeson, A. E., McBride, B. W., Hudson, M. J., Hall, G., and Leach S. A. (1998) Experimental campylobacter infection and diarrhoea in immunodeficient mice. J. Med. Microbiol. 47, 799–809.
Hondalus, M. K., Bardarov, S., Russell, R., Chan, J., Jacobs, W. R., and Bloom, B. (2000) Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect. Immun. 68, 2888–2898.
Smith, D. A., Parish, T., Stoker, N. G., and Bancroft, G. J. (2001) Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidate. Infect. Immun. 69, 1142–1150.
Winslow, G. M., Yager, E., Shilo, K., Volk, E., Reilly, A., and Chu, F. K. (2000) Antibody-mediated elimination of the obligate intracellular bacterial pathogen Erlichia chaffeensis during active infection. Infect. Immun. 68, 2187–2195.
Paciorkowski, N., Porte, P., Shultz, L. D., and Rajan, T. V. (2000) B1 B lymphocytes play a critical role in host protection against lymphatic filarial parasites. J. Exp. Med. 191, 731–735.
Morrison, L. A., Zhu, L., and Thebeau, L. G. (2001) Vaccine-induced serum immunoglobulin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T-cells. J. Virol. 75, 1195–1204.
Derby, M. A., Alexander-Miller, M. A., Tse, R., and Berkofsky, J. A. (2001) High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J. Immunol. 166, 1690–1697.
Cao, T., Meuleman, P., Deambere, I., Sallberg, M., and Leroux-Roels, G. (2001) In vivo inhibition of anti-hepatitis B virus core antigen (HbcAg) immunoglobulin G production by HbcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model. J. Virol. 75, 11,449–11,456.
Hoft, D. F., Schnapp, A. R., Eickhoff, C. S., and Roodman, S. T. (2000) Involvement of CD4+ Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosma cruzi. Infect. Immun. 68, 197–204.
Zhong, W., Gern, L., Stehle, T., Museteanu, C., Kramer, M., Wallich, R., and Simon, M. M. (1999) Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive but not active immunization using recombinant OspC. Eur. J. Immunol. 29, 946–957.
Naito, S., Okada, Y., Takahashi, M., Kato, H., Taneichi, M., Ami, Y., et al. (2000) Anti-tetanus toxoid antibody production and protection against lethal doses of tetanus toxin in hu-PBL-SCID mice. Int. Arch. Allergy Immunol. 123, 149–154.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Dennis, M.J. (2003). Severe Combined Immunodeficient (SCID) Mice in Vaccine Assessment. In: Robinson, A., Hudson, M.J., Cranage, M.P. (eds) Vaccine Protocols. Methods in Molecular Medicine™, vol 87. Humana Press. https://doi.org/10.1385/1-59259-399-2:313
Download citation
DOI: https://doi.org/10.1385/1-59259-399-2:313
Publisher Name: Humana Press
Print ISBN: 978-1-58829-140-0
Online ISBN: 978-1-59259-399-6
eBook Packages: Springer Protocols